These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14100236)

  • 1. [CLINICAL TRIALS OF A NEW SYNTHETIC HEPARINOID: CB-8,061].
    CHASSAGNON C; PERRIN A; MEY JP
    Lyon Med; 1963 Dec; 210():1125-41. PubMed ID: 14100236
    [No Abstract]   [Full Text] [Related]  

  • 2. [USE OF A SYNTHETIC HEPARINOID: CB 8061. CONSIDERATIONS ON 50 CASES AFTER 10 MONTHS OF CLINICAL AND BIOLOGICAL TRIALS].
    MANS J; GENES M
    J Med Bord; 1963 Dec; 140():1886-93. PubMed ID: 14099058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Survey of lipid metabolism in 100 patients suspected of atherosclerosis. Therapeutic trial of a new synthetic heparinoid: CB 8061. (Apropos of 30 cases)].
    LEBLOIS J; LESAGE R; RIVET E
    Lille Med; 1962 Mar; 7():256-63. PubMed ID: 14463327
    [No Abstract]   [Full Text] [Related]  

  • 4. [USE OF A SYNTHETIC HEPARINOID IN LIPID METABOLISM DISORDERS. PRELIMINARY STUDY].
    RABY C; SAINT-BLANCARD J; PAGE G; BIED B; VIGNE J; OUGIER J
    Sem Ther; 1963 Dec; 39():658-64. PubMed ID: 14116089
    [No Abstract]   [Full Text] [Related]  

  • 5. [ACTION OF A SYNTHETIC HEPARINOID ON THE HUMORAL SYNDROME OF ATHEROSCLEROSIS].
    RAYNAUD R; BROCHIER ; TADEI
    Rev Atheroscler; 1963; 5():23-31. PubMed ID: 14121729
    [No Abstract]   [Full Text] [Related]  

  • 6. [BIOLOGICAL AND CLINICAL STUDY OF A PENTOSANE SULFURIC ESTER. CB 8. 061, WITH ESSENTIALLY LIPIDOLYTIC OR LIPIDPHORETIC ACTION].
    GEOFFROY H; DEZOTTEUX H; OPPENHEIM E; DAOUDI M
    Maroc Med; 1964 Mar; 43():275-9. PubMed ID: 14141988
    [No Abstract]   [Full Text] [Related]  

  • 7. [CLEARING ACTION OF HEPARIN AND HEPARINOID SUBSTANCES IN THERAPY OF ARTERIOSCLEROSIS].
    MEONI G
    Clin Ter; 1965 Mar; 32():445-60. PubMed ID: 14333171
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effects, therapeutic indications and posology of synthetic heparinoid 8.061 CB].
    Bourgeois S; Noel B
    Phlebologie; 1967; 20(3):321-8. PubMed ID: 4168153
    [No Abstract]   [Full Text] [Related]  

  • 9. [CLINICAL TRIALS OF A SYNTHETIC HEPARINOID: CB 8.061, IN CARDIOVASCULAR THERAPEUTICS].
    MARTIN-NOEL P; GRUNWALD D
    J Med Lyon; 1964 May; 45():1051-64. PubMed ID: 14158075
    [No Abstract]   [Full Text] [Related]  

  • 10. [THERAPEUTIC TRIAL OF A SYNTHETIC HEPARINOID IN ARTERIAL DISEASES OF THE EXTREMITIES (CAUSED BY ATHEROSCLEROSIS)].
    PIERRON J
    Mars Med; 1963; 100():1267-74. PubMed ID: 14103616
    [No Abstract]   [Full Text] [Related]  

  • 11. HEPARIN-LIKE SUBSTANCES AND ATHEROSCLEROSIS; A CLINICAL SURVEY AFTER FOUR YEARS OF THERAPEUTIC USE OF A DUODENAL HEPARINOID.
    COSTA U; AZZENA D; ASTENGO F; GHIGLIOTTI G
    G Gerontol; 1964 Feb; 12():201-2. PubMed ID: 14163031
    [No Abstract]   [Full Text] [Related]  

  • 12. [On oral treatment with heparin and heparinoids].
    HEYMANN W
    Bibl Haematol; 1963; 15():132-9. PubMed ID: 13954327
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACTION OF A DUODENAL HEPARINOID ON PLASMA LIPIDS AND SUGARS].
    BERRETA JA; CAMPAGNOLI M; SALITA S; LOFFLER AJ; ZUNDER J; PRESS L; BARBEITOARANDA A; KALINOV A
    Prensa Med Argent; 1964 Nov; 51():1267-71. PubMed ID: 14240198
    [No Abstract]   [Full Text] [Related]  

  • 14. [ACTION OF A HEPARINOID IN ARTERIOSCLEROTICS UNDER ANTICOAGULANT THROMBOLYTIC TREATMENT].
    MORELLI AC
    Sem Med; 1963 Dec; 123():1879-84. PubMed ID: 14168961
    [No Abstract]   [Full Text] [Related]  

  • 15. The blood heparinoid substances in human atherosclerosis.
    NIKKILA EA; MAJANEN S
    Scand J Clin Lab Invest; 1952; 4(3):204-10. PubMed ID: 13014993
    [No Abstract]   [Full Text] [Related]  

  • 16. [Trial of a synthetic heparinoid in the treatment of atherogenic dyslipemia].
    Broustet P; Dallocchio M; Crockett R; Bricaud H
    Gaz Med Fr; 1965 Oct; 72(20):3513-7. PubMed ID: 4159547
    [No Abstract]   [Full Text] [Related]  

  • 17. THE EFFECT OF TRIPARANOL AND OF HEPARINOID ON SPONTANEOUS ATHEROSCLEROSIS OF HENS.
    MALINOW MR; MARINI MA; LEMA B; NEBBIA M; BERARDI JA
    Acta Physiol Lat Am; 1964; 14():71-6. PubMed ID: 14175168
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic results with a pancreatic heparinoid with hypocholesterolemic action].
    MUZZOLINI M; DAL FABBRO G; CARRATU R
    Rass Fisiopatol Clin Ter; 1961 Jan; 33():16-28. PubMed ID: 14477646
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical aspects of the hypocholesterolemic and clearing action of a heparinoid and its relation to atherosclerosis].
    ALMAFARA ML; ORLANDO MM
    Sem Med; 1962 Mar; 120():433-6. PubMed ID: 13860649
    [No Abstract]   [Full Text] [Related]  

  • 20. [LIPOLYTIC ACTIVITY OF SOME ANTI-ATHEROSCLEROTIC DRUGS].
    SCHOEN H; SAUER M
    Arzneimittelforschung; 1963 Aug; 13():718-22. PubMed ID: 14085927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.